[ Price : $8.95]
FDA releases the form FDA-483 with two observations from an inspection at the Pharmaneek non-sterile drug manufacturing facility i...[ Price : $8.95]
FDA closes a potential enforcement action against Whoop Inc., reversing an earlier regulatory position that raised questions about...[ Price : $8.95]
Drug company executives recommend ways FDA could increase the use of real-world evidence in regulatory decisions.[ Price : $8.95]
FDA warns Canadas Jubilant HollisterStier General Partnership about CGMP violations in its manufacturing of finished drugs.[ Price : $8.95]
HHS unveils a broad, department-wide initiative aimed at speeding clinical research, reducing regulatory barriers, and attracting ...[ Price : $8.95]
Regenxbio reaches an agreement with FDA on a path toward a potential accelerated approval of Navsunli (clemidsogene lanparvovec-sn...[ Price : $8.95]
A new journal article finds substantial differences in how major international regulators evaluate and approve oncology drugs that...